22 May 2013
Keywords: new, drugs, may, address, hiv, brain, investigational
Article | 15 June 1998
Two investigational drugs from US firms Vertex Pharmaceuticals andDuPont Merck have shown early promise in tackling HIV infection in the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 June 1998
© 2013 thepharmaletter.com